Get Started
Multiple Sclerosis Curricula
Step 1
These independent CME activities are supported by educational grants from Genentech, Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Clinical Context:
Multiple Sclerosis
  1. Course List
faculty image
Patricia K. Coyle, MD
  • Professor, Department of Neurology
  • Vice Chair, Clinical Affairs
  • Director, MS Comprehensive Care Center
  • Stony Brook Medicine
  • Stony Brook, New York

  • Clinical Context: Multiple Sclerosis is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple sclerosis.

    The curriculum includes four case studies at the point of care and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the ANA 2015 140th Annual Meeting of the American Neurological Association, ECTRIMS 2015 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, and Neuroscience 2015 Society for Neuroscience Annual Meeting.
  • Describe the natural history of multiple sclerosis, the importance of early diagnosis of this condition, and recent advances in our understanding of components of the pathophysiologic mechanisms that may serve as targets of therapy.
  • Evaluate criteria that have been developed to assess treatment response in multiple sclerosis and delineate how these criteria can be used to risk-stratify patients in clinical practice.
  • Formulate personalized treatment regimens that improve patient outcomes based on an understanding of the mechanism of action, efficacy and safety profiles of current and emerging treatment options.
  • Target Audience

    This series of activities is designed for neurologists, primary care physicians, internists, family practice practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved in the screening and treatment of patients with multiple sclerosis.


    Activity Goal

    The goal of this program is to provide information and case studies at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in multiple sclerosis.